Soligenix announces recent accomplishments and third quarter 2020 financial results

Princeton, n.j., nov. 12, 2020 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent...
SNGX Ratings Summary
SNGX Quant Ranking